CDC and FDA Now Advising Healthcare Providers Not to Use Products Made by NECC Until Further Notice

CDC and FDA Now Advising Healthcare Providers Not to Use Products Made by NECC Until Further Notice

 

With the death toll from a nationwide outbreak of a rare fungal meningitis now at 14, and 170 cases reported in 12 states, both the Centers for Disease Control (CDC) and the Food and Drug Administration has recommended that all heath care personnel cease using any product made by New England Compounding Center (NECC) in Framingham, Massachusetts.  NECC is the pharmaceutical compounding company maker of the steroid believed to be the source of the lethal outbreak.

The steroid is used as a painkiller, usually used to alleviate back pain, and could have been injected in some 13,000 patients, authorities have said.

The government has identified about 75 facilities in 23 states that received the recalled doses. The fungus is not transmitted from person to person.

Clinicians should contact patients who received potentially contaminated injections starting May 21, the CDC has said. Once identified, patients with infections should be put on appropriate anti-fungal therapy.

Meningitis is an inflammation of the lining of the brain and spinal cord. Infected patients have developed a variety of symptoms, which set in one to four weeks after their injections. These include fever, a new or worsening headache, nausea and problems similar to those seen in a stroke.

(Sources, USA Today, Centers for Disease Control (CDC))